Makoto Inoue
Direttore/Membro del Consiglio presso Id Pharma Co., Ltd.
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Toyotaka Mori | M | 65 |
Id Pharma Co., Ltd.
Id Pharma Co., Ltd. BiotechnologyHealth Technology Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan. | 10 anni |
Tsugumine Shu | M | 66 |
Id Pharma Co., Ltd.
Id Pharma Co., Ltd. BiotechnologyHealth Technology Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan. | 20 anni |
Kiyomi Kindaichi | F | 61 |
Id Pharma Co., Ltd.
Id Pharma Co., Ltd. BiotechnologyHealth Technology Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan. | 15 anni |
Kunikatsu Shirahata | M | - |
Id Pharma Co., Ltd.
Id Pharma Co., Ltd. BiotechnologyHealth Technology Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan. | 20 anni |
Yoshikazu Yonemitsu | M | 61 |
Kyushu University
| 34 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Masaharu Inoue | M | 62 |
Id Pharma Co., Ltd.
Id Pharma Co., Ltd. BiotechnologyHealth Technology Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan. | - |
Yohei Tanida | M | 62 |
Id Pharma Co., Ltd.
Id Pharma Co., Ltd. BiotechnologyHealth Technology Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan. | - |
Kyohei Morita | M | - |
Kyushu University
| 4 anni |
Soushi Ikeda | M | 56 |
Kyushu University
| 4 anni |
Shiro Toba | M | 57 |
Id Pharma Co., Ltd.
Id Pharma Co., Ltd. BiotechnologyHealth Technology Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan. | - |
Jian Ding | M | 71 |
Kyushu University
| 3 anni |
Huai Dong Wang | M | 59 |
Kyushu University
| 3 anni |
Masanori Yoshitake | M | 51 |
Kyushu University
| 4 anni |
Michitaka Goto | M | 58 |
Kyushu University
| 4 anni |
Xiang Dong He | M | 61 |
Kyushu University
| 3 anni |
Hideo Umeki | M | 60 |
Kyushu University
| 4 anni |
Shigeru Nakashima | M | - |
Kyushu University
| 4 anni |
Mohammad Jonaid Shafiq | M | 63 |
Kyushu University
| 3 anni |
Shinya Tamura | M | 57 |
Kyushu University
| 2 anni |
Rui Ping Dong | M | 62 |
Kyushu University
| 3 anni |
Tetsuo Mitsuyasu | M | - |
Kyushu University
| 4 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Giappone | 21 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Makoto Inoue
- Contatti personali